2018, Chronic Condition, Individual and Management

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

Chronic Condition

Individual

Management

Rethinking Opioid Conversions: Mary Lynn McPherson and Drew Rosielle

GeriPal

MAY 19, 2022

I think part of it’s the math, but I think what really happened is, I think the story here is that in 2018, MD Anderson published this really landmark study by Dr. Reddy and her colleagues about going from IV Dilaudid to other to oral Dilaudid, oral hydromorphone, I should say, oral morphine and oral oxycodone. Is that right?

IT Patients Individual Relationship

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

SEPTEMBER 13, 2021

In 2018, Trump’s Department of Health and Human Services (HHS) released its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs , but the edifice envisioned by the Blueprint largely failed to materialize. Drug Price Negotiation to Benefit Medicare and Commercial Plans. Part D currently has no such cap.

Manufacturing

Manufacturing Supply Chain Patient-Centered Utilities

Primary Care Digest

Rethinking Opioid Conversions: Mary Lynn McPherson and Drew Rosielle

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

Stay Connected